310 related articles for article (PubMed ID: 28474265)
1. Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
Tonella L; Giannoccaro M; Alfieri S; Canevari S; De Cecco L
Curr Treat Options Oncol; 2017 May; 18(5):32. PubMed ID: 28474265
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
De Cecco L; Bossi P; Locati L; Canevari S; Licitra L
Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125
[TBL] [Abstract][Full Text] [Related]
3. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
4. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
6. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
[TBL] [Abstract][Full Text] [Related]
7. A poor prognosis subtype of HNSCC is consistently observed across methylome, transcriptome, and miRNome analysis.
Jung AC; Job S; Ledrappier S; Macabre C; Abecassis J; de Reyniès A; Wasylyk B
Clin Cancer Res; 2013 Aug; 19(15):4174-84. PubMed ID: 23757353
[TBL] [Abstract][Full Text] [Related]
8. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
9. Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer.
Bie T; Zhang X
J Immunol Res; 2021; 2021():8569575. PubMed ID: 34977258
[TBL] [Abstract][Full Text] [Related]
10. CAFE MOCHA: An Integrated Platform for Discovering Clinically Relevant Molecular Changes in Cancer-An Example of Distant Metastasis- and Recurrence-Linked Classifiers in Head and Neck Squamous Cell Carcinoma.
Krishnan NM; I M; Hariharan J; Panda B
JCO Clin Cancer Inform; 2018 Dec; 2():1-11. PubMed ID: 30652568
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy.
Schmidt S; Linge A; Zwanenburg A; Leger S; Lohaus F; Krenn C; Appold S; Gudziol V; Nowak A; von Neubeck C; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Baumann M; Krause M; Löck S;
Clin Cancer Res; 2018 Mar; 24(6):1364-1374. PubMed ID: 29298797
[No Abstract] [Full Text] [Related]
12. Detection of Distinct Changes in Gene-expression Profiles in Specimens of Tumors and Transition Zones of Tenascin-positive/-negative Head and Neck Squamous Cell Carcinoma.
Zivicova V; Gal P; Mifkova A; Novak S; Kaltner H; Kolar M; Strnad H; Sachova J; Hradilova M; Chovanec M; Gabius HJ; Smetana K; Fik Z
Anticancer Res; 2018 Mar; 38(3):1279-1290. PubMed ID: 29491051
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into head and neck cancer using next-generation "omic" technologies.
Sepiashvili L; Bruce JP; Huang SH; O'Sullivan B; Liu FF; Kislinger T
Cancer Res; 2015 Feb; 75(3):480-6. PubMed ID: 25589349
[TBL] [Abstract][Full Text] [Related]
14. Molecular Aspects of Head and Neck Cancer Therapy.
Puram SV; Rocco JW
Hematol Oncol Clin North Am; 2015 Dec; 29(6):971-92. PubMed ID: 26568543
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
[TBL] [Abstract][Full Text] [Related]
16. Immune signaling-based Cascade Propagation approach re-stratifies HNSCC patients.
Liu K; Chyr J; Zhao W; Zhou X
Methods; 2016 Dec; 111():72-79. PubMed ID: 27339942
[TBL] [Abstract][Full Text] [Related]
17. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays.
Rickman DS; Millon R; De Reynies A; Thomas E; Wasylyk C; Muller D; Abecassis J; Wasylyk B
Oncogene; 2008 Nov; 27(51):6607-22. PubMed ID: 18679425
[TBL] [Abstract][Full Text] [Related]
18. Is gene expression profiling of head and neck cancers ready for the clinic?
Ziober AF; D'Alessandro L; Ziober BL
Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
[TBL] [Abstract][Full Text] [Related]
19. Heads Up! Predictive Gene Signatures in Head and Neck Cancer May Be Coming Soon.
Chau NG; Hammerman PS
Clin Cancer Res; 2016 Aug; 22(15):3710-2. PubMed ID: 27129579
[TBL] [Abstract][Full Text] [Related]
20. Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis.
Nowicka Z; Stawiski K; Tomasik B; Fendler W
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]